Clinical Trials Logo

Clinical Trial Summary

The main objective is to determine the medical fate (transplanted or not and living or deceased), of patients with Severe, fulminating acute liver failure in the public hospitals of paris.


Clinical Trial Description

Severe, fulminating acute liver failure is a rare but serious disease. The overall prognosis has improved in recent years thanks to advances in medical management and liver transplantation. However, the epidemiology of this disease in France, the survival with or without liver transplantation of these patients and the factors that can influence this survival are not well known. The main objective is to determine the medical fate (transplanted or not and living or deceased), of patients with Severe, fulminating acute liver failure in the public hospitals of paris (APHP). The data will come from the APHP Health Data Warehouse ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04658407
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact Philippe ICHAI
Phone 01 45 59 64 35
Email philippe.ichai@aphp.fr
Status Not yet recruiting
Phase
Start date April 1, 2021
Completion date December 1, 2021